148 results on '"Akarca, Ayse"'
Search Results
2. Mitochondrial dsRNA from B-ALL cells stimulates mesenchymal stromal cells to become cancer-associated fibroblasts
3. Self-supervised deep learning for highly efficient spatial immunophenotyping
4. ConCORDe-Net: Cell Count Regularized Convolutional Neural Network for Cell Detection in Multiplex Immunohistochemistry Images
5. Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma
6. Geospatial immune variability illuminates differential evolution of lung adenocarcinoma
7. Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress
8. Microenvironmental immune cell alterations across the spectrum of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma
9. Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study
10. Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours
11. Impact of MYC and BCL2 double expression on outcomes in primary CNS lymphoma: a UK multicenter analysis
12. Correction to: Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program
13. Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program
14. CD47 expression in acute myeloid leukemia varies according to genotype
15. Phenotyping of lymphoproliferative tumours generated in xenografts of non-small cell lung cancer
16. Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma
17. Targeting the T cell receptor [beta]-chain constant region for immunotherapy of T cell malignancies
18. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
19. Impact of Double Expression of MYC and BCL-2 on Outcomes in Primary CNS Lymphoma: A UK Multicentre Analysis
20. LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L
21. Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers
22. Abstract 3096: Multi-region patient-derived xenograft models from non-small cell lung cancer patients enrolled in lung TRACERx
23. Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors
24. Correction to: Single‑cell profiling of myasthenia gravis identifies a pathogenic T cell signature
25. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma
26. Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
27. Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy.
28. Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution
29. Immunohistochemical studies for identification of biomarkers in haematological malignancies: An approach for potential novel therapeutic targets
30. Induction of APOBEC3 exacerbates DNA replication stress and chromosomal instability in early breast and lung cancer evolution
31. Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution
32. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature
33. Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma
34. The lifespan and kinetics of human dendritic cell subsets and their precursors in health and inflammation
35. Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression
36. Megakaryocytes, erythropoietic and granulopoietic cells express CAL2 antibody in myeloproliferative neoplasms carrying CALR gene mutations
37. Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4+ T Cells
38. Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response
39. PD-L1 expressing granulomatous reaction as an on-target mechanism of steroid-refractory immune hepatotoxicity
40. Role of Epstein-Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature
41. Hypoxic adaptation of leukemic cells infiltrating the CNS affords a therapeutic strategy targeting VEGFA
42. Megakaryocytes, erythropoietic and granulopoietic cells express CAL2 antibody in myeloproliferative neoplasms carrying CALR gene mutations.
43. Cytotoxic CD4+ Cells in Chronic Lymphocytic Leukaemia: An Extended Immunophenotypic Analysis Examining Their Association with Cytomegalovirus Serostatus and Similarities with Cytotoxic CD8+ Cells
44. Erratum: Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
45. Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies
46. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
47. VEGFA- a New Therapeutic Target in CNS Leukemia
48. Targeting T-Cell Receptor β-Constant Domain for Immunotherapy of T-Cell Malignancies
49. ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer–Containing Antibody–Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies
50. Mechanistic and Pharmacodynamic Studies of Adct-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.